Impact Factor
3.62
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.35
430 total citations
h5-index
29
h5 depth signal
Cited share
78.7%
96 of 122
Total citations
430
Citation footprint
Metric signal
3.80
External metric anchor
Self-citation
0.5%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
144
China
131
France
42
Germany
32
United Kingdom
23
Citing Fields of Research
Immunology
280
Genetics & Genomics
91
Musculoskeletal Disorders
38
Auto-Inflammatory Disorders
31
Hematology
28
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,935
Articles tracked across the journal lifetime
Indexed publication set
122
96 cited publications
Last 12 months
54
4.5 publications/month
Open access share
37.0%
20 OA publications in the last year
Leading citing country
United States
144 citing publications
Leading citing field
Immunology
280 citing publications
Latest tracked publication
29 September 2026
10 recent records available
Coverage & Indexing History
v1n1, Sept. 1999-
v1n1, Sept. 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Broad Categories
Allergy and Immunology
Molecular Biology
Immunology
Cancer, Autophagy & Apoptosis
Hematology
Genetics & Genomics
Musculoskeletal Disorders
Noncoding RNA
MeSH Descriptors
Genetic Therapy
Immune System
Immunogenetics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1038/s41435-026-00412-3
Open DOI
PRSS1 isoforms promote type 2 immune responses in IgG4-related disease
Trypsin is commonly used as an adjunctive therapeutic agent for chronic inflammatory and autoimmune diseases. This study investigated the impact of trypsinogen (PRSS1) variants on type 2 immune responses mediated by M2 macrophage polariz...
03
DOI 10.1038/s41435-026-00408-z
Open DOI
Large-scale GWAS meta-analysis of serum antibody levels in healthy individuals reveals distinct genetic architectures
Antibodies are the principal effector proteins of humoral immunity. Dysregulated antibody production is a feature of a number of heritable immune-mediated diseases, such as the antibody deficiencies and IgA nephropathy. To characterize t...
04
DOI 10.1038/s41435-026-00411-4
Open DOI
Compartment-specific regulation of stromal differentiation of the spleen in health and disease
Peripheral lymphoid organs in mammals are highly organized, complex tissues that support adaptive immune responses. In terms of comparative developmental biology, the mobile leukocytes of shared hematopoietic lineages in the spleen, lymp...
05
DOI 10.1038/s41435-026-00407-0
Open DOI
SERPINH1 derived from cancer-associated fibroblasts promotes epithelial-mesenchymal transition in clear cell renal cell carcinoma
Despite advances in cancer treatment, the prognosis of clear cell renal cell carcinoma (ccRCC) remains poor. The role of CAFs in ccRCC remains unclear. The single-cell sequencing (scRNA-seq) data for ccRCC were downloaded from the GEO da...
06
DOI 10.1038/s41435-026-00410-5
Open DOI
Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling
07
DOI 10.1038/s41435-026-00409-y
Open DOI
A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer
08
DOI 10.1038/s41435-026-00406-1
Open DOI
The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients
Tumor-infiltrating lymphocytes (TILs) shape melanoma behavior and response to immunotherapy, but the links between immune regulation, TIL patterning, and outcomes remain unclear. We retrospectively studied 32 primary melanoma samples fro...
09
DOI 10.1038/s41435-026-00404-3
Open DOI
Potential role of Akkermansia massiliensis in multiple sclerosis protection by the FcRL3 gene
The contribution of human genetics in shaping the abundance of gut microbiota is small, about 5%; however, it can inform about disease etiopathogenesis, including multiple sclerosis (MS). Searching for MS-gut microbiota cross-comparison ...
10
DOI 10.1038/s41435-026-00405-2
Open DOI
Genetic regulation of platelet-derived BDNF by rs11030119: discrepancy between circulating levels and hemostatic function
Brain-Derived Neurotrophic Factor (BDNF), highly enriched in platelets, contributes to vascular integrity and thrombotic responses. The rs11030119 variant, located in a BDNF intronic enhancer, has been linked to stroke recovery, but its ...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 5 (June 2000); title from cover.
Also issued online.
v. 1, no. 1 (Sep. 1999)20010129 Notice published Printed on acid-free paper